Michelle Trevisin

517 total citations
9 papers, 401 citations indexed

About

Michelle Trevisin is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Nephrology. According to data from OpenAlex, Michelle Trevisin has authored 9 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Genetics and 4 papers in Nephrology. Recurrent topics in Michelle Trevisin's work include Vasculitis and related conditions (9 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers) and Renal Diseases and Glomerulopathies (4 papers). Michelle Trevisin is often cited by papers focused on Vasculitis and related conditions (9 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers) and Renal Diseases and Glomerulopathies (4 papers). Michelle Trevisin collaborates with scholars based in Australia, New Zealand and United States. Michelle Trevisin's co-authors include Judy Savige, Wendy Pollock, Richard Wong, J. Charles Jennette, Marvin J. Fritzler, Allan Wiik, E. Chris Hagen, Charles D. Pusey, James A. Goeken and Wayne Dimech and has published in prestigious journals such as Journal of Clinical Pathology, Journal of Immunological Methods and American Journal of Clinical Pathology.

In The Last Decade

Michelle Trevisin

9 papers receiving 385 citations

Peers

Michelle Trevisin
Sven Weidner Germany
RA Watts United Kingdom
J Zabka Czechia
Jos Austen Netherlands
A. Bernard Collins United States
P Lesavre France
F Liozon France
Sven Weidner Germany
Michelle Trevisin
Citations per year, relative to Michelle Trevisin Michelle Trevisin (= 1×) peers Sven Weidner

Countries citing papers authored by Michelle Trevisin

Since Specialization
Citations

This map shows the geographic impact of Michelle Trevisin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Trevisin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Trevisin more than expected).

Fields of papers citing papers by Michelle Trevisin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Trevisin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Trevisin. The network helps show where Michelle Trevisin may publish in the future.

Co-authorship network of co-authors of Michelle Trevisin

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Trevisin. A scholar is included among the top collaborators of Michelle Trevisin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Trevisin. Michelle Trevisin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Savige, Judy, Michelle Trevisin, & Wendy Pollock. (2018). Testing and reporting antineutrophil cytoplasmic antibodies (ANCA) in treated vasculitis and non-vasculitic disease. Journal of Immunological Methods. 458. 1–7. 9 indexed citations
3.
Pollock, Wendy, Michelle Trevisin, & Judy Savige. (2008). Testing on formalin-fixed neutrophils is less sensitive and specific for small vessel vasculitis, and less sensitive for MPO-ANCA, than most ELISAs. Journal of Immunological Methods. 339(2). 141–145. 11 indexed citations
4.
Trevisin, Michelle, Wendy Pollock, Wayne Dimech, & Judy Savige. (2008). Evaluation of a multiplex flow cytometric immunoassay to detect PR3- and MPO-ANCA in active and treated vasculitis, and in inflammatory bowel disease (IBD). Journal of Immunological Methods. 336(2). 104–112. 25 indexed citations
5.
Trevisin, Michelle, Wendy Pollock, Wayne Dimech, et al.. (2007). Antigen-Specific ANCA ELISAs Have Different Sensitivities for Active and Treated Vasculitis and for Nonvasculitic Disease. American Journal of Clinical Pathology. 129(1). 42–53. 25 indexed citations
6.
Savige, Judy, Wendy Pollock, & Michelle Trevisin. (2005). What do antineutrophil cytoplasmic antibodies (ANCA) tell us?. Best Practice & Research Clinical Rheumatology. 19(2). 263–276. 50 indexed citations
7.
Trevisin, Michelle, Paul J. Neeson, & Judy Savige. (2004). The binding of proteinase 3 antineutrophil cytoplasmic antibodies (PR3-ANCA) varies in different ELISAs. Journal of Clinical Pathology. 57(3). 303–308. 10 indexed citations
8.
Savige, Judy, Wayne Dimech, Marvin J. Fritzler, et al.. (2003). Addendum to the International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies. American Journal of Clinical Pathology. 120(3). 312–318. 132 indexed citations
9.
Savige, Judy, Marvin J. Fritzler, James A. Goeken, et al.. (2003). Addendum to the International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies: Quality Control Guidelines, Comments, and Recommendations for Testing in Other Autoimmune Diseases. American Journal of Clinical Pathology. 120(3). 312–318. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026